Therapeutic uses of biocompatible biogel compositions
OwnerAlyssa Panitch, Brandon Sealinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to biocompatible biogel compositions and methods of drug delivery. The biocompatible biogel is a physical polymer matrix formed via affinity interactions between its components. The components of the biocompatible biogel comprise a cationic component, an anionic component, and optionally a therapeutic agent.
Claims76
A method for treating a wound with a biocompatible biogel composition, the method comprising the steps:
- (a) providing a biocompatible biogel comprising
- (i) a cationic component, wherein the cationic component comprises a hydrophilic polymer having a molecular weight greater than about 3000 g/mole, but less than about 10,000,000 g/mole, to which at least about 3 cationic oligomers, but no more than 1,000,000 cationic oligomers is grafted;
- and
- (ii) an anionic component;
- and
- (iii) optionally a therapeutically effective amount of a therapeutic agent;
- and
- (b) forming a biocompatible matrix to support wound healing.
A method for supporting differentiation of isolated differentiable cells into a mature phenotype, the method comprising steps:
- (1) providing a biocompatible biogel composition comprising:
- (a) a biogel for growing isolated differentiable cells, the biogel comprising
- (i) a cationic component, wherein the cationic component comprises a hydrophilic polymer having a molecular weight from about 3000 g/mole to about 10,000,000 g/mole, wherein the hydrophilic polymer comprises at least about 3 cationic oligomer grafts to about 1,000,000 cationic oligomer grafts;
- and
- (ii) an anionic component;
- and
- (b) isolated differentiable cells;
- (2) administering the biocompatible biogel composition into a region of interest to a subject in need thereof;
- (3) forming a tissue scaffold to support differentiation of isolated cells into a mature phenotype.
A biomedical device comprising a biocompatible biogel composition disposed on the device, the biogel composition comprising
- (i) a cationic component, wherein the cationic component comprises a hydrophilic polymer having a molecular weight from about 3000 g/mole to about 10,000,000 g/mole, wherein the hydrophilic polymer comprises at least about 3 cationic oligomer grafts to about 1,000,000 cationic oligomer grafts;
- and
- (ii) an anionic component;
- and
- wherein the biogel composition improves at least one anti-adhesive property of the device.
A method for treating inflammation with a biocompatible biogel composition, the method comprising the steps:
- (i) providing a biocompatible biogel composition comprising
- (a) a cationic component;
- wherein the cationic component comprises a hydrophilic polymer having a molecular weight great than about 3000 g/mole, but less than about 10,000,000 g/mole, to which at least about 3, but no more than 1,000,000 cationic oligomers is grafted;
- (b) an anionic component;
- and
- (c) a therapeutically effective amount of a therapeutic agent;
- (ii) administering the biocompatible biogel composition of step (i) to a region of interest within a subject in need thereof, wherein the region of interest contains or is adjacent to an area of inflammation;
- thereby reducing the inflammation.
The method according to 58, wherein the biological agent is an isolated cell.
A tissue filler to fill a tissue void, comprising
- (a) a gel-like system comprising
- (i) a cationic component, wherein the cationic component comprises a hydrophilic polymer having a molecular weight great than about 3000 g/mole, but less than about 10,000,000 g/mole, to which at least about 3, but no more than 1,000,000 cationic oligomers is grafted;
- and
- (ii) an anionic component;
- (b) and optionally a therapeutically effective amount of a therapeutic agent.
Dependencies are inferred from the claim text.